Lindbrook Capital, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 207 filers reported holding CARDLYTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$2,096127
+746.7%
0.00%
Q3 2022$0
-100.0%
15
-68.1%
0.00%
Q2 2022$1,000
-75.0%
47
-29.9%
0.00%
-100.0%
Q1 2022$4,000
+100.0%
67
+103.0%
0.00%
Q4 2021$2,000
-33.3%
330.0%0.00%
-100.0%
Q3 2021$3,000
-25.0%
330.0%0.00%0.0%
Q2 2021$4,0000.0%330.0%0.00%0.0%
Q1 2021$4,000
-20.0%
330.0%0.00%0.0%
Q4 2020$5,000
+150.0%
330.0%0.00%0.0%
Q3 2020$2,0000.0%330.0%0.00%0.0%
Q2 2020$2,000330.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders